“Soluble Epoxide Hydrolase Inhibition and Insulin Resistance”
The purpose of this study is to test how soluble epoxide hydrolase (sEH) inhibition with GSK2256294 affects tissue sEH activity and insulin sensitivity.
Drug - GSK2256294
Drug will be taken daily by mouth for 7 days.
Drug - Placebo oral capsule
Placebo will be taken daily by mouth for 7 days.
Effect of Inhibition Soluble Epoxide Hydrolase on Insulin Sensitivity in Humans